Cantitate/Preț
Produs

Severe Asthma: Toward Personalized Patient Management

Editat de Yong Chul Lee, So Ri Kim, Seong Ho Cho
en Limba Engleză Paperback – 4 sep 2018
This book presents state of the art knowledge on severe asthma with the aim of providing readers with a clear understanding of, first, the heterogeneity of the condition and of patients’ symptom profiles and responses to therapy and, second, the future implications of this heterogeneity for individualized patient care. After an opening section that offers an overview of severe asthma, including its clinical significance, the pathogenesis, available diagnostic approaches, and treatment options are described in detail. The sections on diagnosis and treatment cover the role of biomarkers, the use of radiologic diagnostic modalities, and both pharmacologic and non-pharmacologic therapies, including emerging options that will address hitherto unmet needs of patients. The outcomes of cutting-edge preclinical and clinical research are carefully documented and numerous useful tips provided on patient management. The inclusion of many informative schematic figures will assist readers in grasping the contents easily. The book will be of high value for medical students, researchers, general physicians, specialists, and paramedical staff.
Citește tot Restrânge

Preț: 36916 lei

Preț vechi: 38859 lei
-5%

Puncte Express: 554

Carte tipărită la comandă

Livrare economică 06-11 iulie

Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit de la 40000 lei Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.

Specificații

ISBN-13: 9789811094996
ISBN-10: 9811094993
Pagini: 134
Ilustrații: IX, 134 p. 12 illus., 6 illus. in color.
Dimensiuni: 178 x 254 mm
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore

Cuprins

Section 1: Overview of severe asthma.- 1. Basics of severe asthma in clinical practice.- 2. Heterogeneity in severe asthma.- Section 2: Pathobiology of severe asthma.- 1.Pathogenesis of severe asthma.- Section 3: Diagnostic approaches to severe asthma.- 1. Biomarkers in severe asthma.- 2. Radiologic diagnostic modalities in severe asthma.- Section 4: Current and future therapies for severe asthma.- 1. Pharmacologic therapies.- 2. Non-pharmacologic therapies.

Notă biografică

Yong Chul Lee, MD
Division of Respiratory Medicine and Allergy, Department of Internal Medicine, Chonbuk National University Medical School

So Ri Kim, MD
Division of Respiratory Medicine and Allergy, Department of Internal Medicine, Chonbuk National University Medical School

Seong Ho Cho, MD
Division of Allergy and Immunology, Internal Medicine, Morsani College of Medicine, University of South Florida

Textul de pe ultima copertă

This book presents state of the art knowledge on severe asthma with the aim of providing readers with a clear understanding of, first, the heterogeneity of the condition and of patients’ symptom profiles and responses to therapy and, second, the future implications of this heterogeneity for individualized patient care. After an opening section that offers an overview of severe asthma, including its clinical significance, the pathogenesis, available diagnostic approaches, and treatment options are described in detail. The sections on diagnosis and treatment cover the role of biomarkers, the use of radiologic diagnostic modalities, and both pharmacologic and non-pharmacologic therapies, including emerging options that will address hitherto unmet needs of patients. The outcomes of cutting-edge preclinical and clinical research are carefully documented and numerous useful tips provided on patient management. The inclusion of many informative schematic figures will assist readers in grasping the contents easily. The book will be of high value for medical students, researchers, general physicians, specialists, and paramedical staff.

Caracteristici

Equips readers to offer the best possible patient care, taking into account disease heterogeneity Describes the outcomes of cutting-edge preclinical and clinical research Provides extensive guidance on patient management, including the use of emerging therapies